» Articles » PMID: 35003365

The Regulatory Network of MicroRNA in the Metabolism of Colorectal Cancer

Overview
Journal J Cancer
Specialty Oncology
Date 2022 Jan 10
PMID 35003365
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is the third most common malignant tumor in the world. During the progression of CRC, the entire metabolic network undergoes reprogramming, including marked changes in the regulation of glucose, lipid and amino acid metabolism. Although microRNAs (miRNAs) account for only 1% of the entire human genome, they play an important role in almost all physiological and pathological processes in the body. MiRNAs can react directly with key enzymes in the metabolic processes. MiRNAs also interact with other ncRNAs, as a member of non-coding RNA (ncRNA), to form their own regulatory network in various oncogenic pathways of CRC metabolism. The progression of colorectal cancer is closely related to the intestinal flora, where miRNAs act as important mediators. Understanding how miRNAs act in the regulatory network of CRC metabolism is helpful to elucidate the characteristics of tumor occurrence, proliferation, metastasis and drug resistance. This review summarizes the role of miRNAs in the metabolism of CRC and how miRNAs interact with key enzymes, ncRNA and intestinal flora to further discuss how miRNAs affect CRC and realize some new strategies for the early diagnosis and treatment of CRC.

Citing Articles

Linking microRNA to metabolic reprogramming and gut microbiota in the pathogenesis of colorectal cancer (Review).

Bin Wan Mohd Nor W, Kwong S, Fuzi A, Said N, Jamil A, Lee Y Int J Mol Med. 2025; 55(3).

PMID: 39820715 PMC: 11759585. DOI: 10.3892/ijmm.2025.5487.


Advances in microRNAs as Emerging Biomarkers for Colorectal Cancer Early Detection and Diagnosis.

Zdralevic M, Radovic A, Raonic J, Popovic N, Klisic A, Vuckovic L Int J Mol Sci. 2024; 25(20).

PMID: 39456841 PMC: 11507567. DOI: 10.3390/ijms252011060.


Gut microbiome: decision-makers in the microenvironment of colorectal cancer.

Han J, Zhang B, Zhang Y, Yin T, Cui Y, Liu J Front Cell Infect Microbiol. 2023; 13:1299977.

PMID: 38156313 PMC: 10754537. DOI: 10.3389/fcimb.2023.1299977.


Emerging role of non-coding RNAs in glucose metabolic reprogramming and chemoresistance in colorectal cancer.

Yan S, Wang S, Wang X, Dai W, Chu J, Cheng M Front Oncol. 2022; 12:954329.

PMID: 35978828 PMC: 9376248. DOI: 10.3389/fonc.2022.954329.

References
1.
Wang X, Zhang H, Yang H, Bai M, Ning T, Deng T . Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Mol Oncol. 2020; 14(3):539-555. PMC: 7053238. DOI: 10.1002/1878-0261.12629. View

2.
Fakih M . Metastatic colorectal cancer: current state and future directions. J Clin Oncol. 2015; 33(16):1809-24. DOI: 10.1200/JCO.2014.59.7633. View

3.
Wang J, Wang H, Liu A, Fang C, Hao J, Wang Z . Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer. Oncotarget. 2015; 6(23):19456-68. PMC: 4637298. DOI: 10.18632/oncotarget.3318. View

4.
Sun Y, Zhao X, Zhou Y, Hu Y . miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect. Oncol Rep. 2012; 28(4):1346-52. DOI: 10.3892/or.2012.1958. View

5.
Han R, Sun Q, Wu J, Zheng P, Zhao G . Sodium Butyrate Upregulates miR-203 Expression to Exert Anti-Proliferation Effect on Colorectal Cancer Cells. Cell Physiol Biochem. 2016; 39(5):1919-1929. DOI: 10.1159/000447889. View